Matches in Wikidata for { <http://www.wikidata.org/entity/Q74832930> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q74832930 description "article scientifique publié en 1999" @default.
- Q74832930 description "artículu científicu espublizáu en marzu de 1999" @default.
- Q74832930 description "im März 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74832930 description "scientific article published on 01 March 1999" @default.
- Q74832930 description "wetenschappelijk artikel" @default.
- Q74832930 description "наукова стаття, опублікована в березні 1999" @default.
- Q74832930 name "Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's" @default.
- Q74832930 name "Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's" @default.
- Q74832930 type Item @default.
- Q74832930 label "Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's" @default.
- Q74832930 label "Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's" @default.
- Q74832930 prefLabel "Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's" @default.
- Q74832930 prefLabel "Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's" @default.
- Q74832930 P1433 Q74832930-797AF4EF-DA32-44F9-9F3B-EB460DD46816 @default.
- Q74832930 P1476 Q74832930-5FE2D7BD-6CF4-4BAC-8583-6C5EDCF7677B @default.
- Q74832930 P2093 Q74832930-02EDFC21-901B-440E-9448-491B0A1B541B @default.
- Q74832930 P2093 Q74832930-26D03C35-20EF-4AEA-AAE4-554BA7D47D5A @default.
- Q74832930 P2093 Q74832930-568C9788-BE48-4DE1-B518-BA2B106FEF27 @default.
- Q74832930 P2093 Q74832930-F15525BC-396A-486E-B9B6-37BD3EC6AF80 @default.
- Q74832930 P304 Q74832930-3D9DD2BB-FB26-46CF-8295-E72C01467747 @default.
- Q74832930 P31 Q74832930-69F03CB5-91D3-4511-9CB9-83F0AD54E65F @default.
- Q74832930 P356 Q74832930-7993EC2C-7D74-4077-840E-741C365A3A1D @default.
- Q74832930 P407 Q74832930-5D47579E-F210-462A-B90F-ED1E0F6E3634 @default.
- Q74832930 P433 Q74832930-9C8CADF3-8479-43D1-B732-D3FF93E9231E @default.
- Q74832930 P478 Q74832930-1FFED53C-5EDF-43D0-BE83-3DA47F1D4A7A @default.
- Q74832930 P577 Q74832930-D6E6E065-092F-48F3-889A-7DD6F1CBF053 @default.
- Q74832930 P698 Q74832930-DC531867-2EC8-445C-834B-F34738E432E0 @default.
- Q74832930 P921 Q74832930-54905DCB-8335-4CB9-89B2-D026A29DE71E @default.
- Q74832930 P356 IC981198F @default.
- Q74832930 P698 11670875 @default.
- Q74832930 P1433 Q902828 @default.
- Q74832930 P1476 "Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's" @default.
- Q74832930 P2093 "Francesco P. Intini" @default.
- Q74832930 P2093 "Giovanni Natile" @default.
- Q74832930 P2093 "Hing C. Wong" @default.
- Q74832930 P2093 "Luigi G. Marzilli" @default.
- Q74832930 P304 "1006-1014" @default.
- Q74832930 P31 Q13442814 @default.
- Q74832930 P356 "10.1021/IC981198F" @default.
- Q74832930 P407 Q1860 @default.
- Q74832930 P433 "5" @default.
- Q74832930 P478 "38" @default.
- Q74832930 P577 "1999-03-01T00:00:00Z" @default.
- Q74832930 P698 "11670875" @default.
- Q74832930 P921 Q880 @default.